Stay updated with breaking news from Neil Kumar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating)’s share price gapped up before the market opened on Thursday after SVB Securities raised their price target on the stock from $25.00 to $27.00. The stock had previously closed at $15.18, but opened at $15.58. BridgeBio Pharma shares last traded at $15.87, with a volume of 112,369 shares. […]
BridgeBio Pharma (NASDAQ:BBIO – Get Rating) had its price target hoisted by analysts at SVB Securities from $25.00 to $27.00 in a research note issued on Thursday, The Fly reports. SVB Securities’ target price points to a potential upside of 77.87% from the stock’s current price. Several other equities research analysts also recently commented on […]
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) CEO Neil Kumar sold 120,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 5th. The shares were sold at an average price of $15.46, for a total transaction of $1,855,200.00. Following the completion of the transaction, the chief executive officer now directly owns […]
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) CFO Brian C. Stephenson sold 55,500 shares of BridgeBio Pharma stock in a transaction that occurred on Wednesday, April 5th. The stock was sold at an average price of $15.45, for a total value of $857,475.00. Following the completion of the transaction, the chief financial officer now directly […]
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) CFO Brian C. Stephenson sold 55,500 shares of BridgeBio Pharma stock in a transaction dated Wednesday, April 5th. The stock was sold at an average price of $15.45, for a total value of $857,475.00. Following the completion of the transaction, the chief financial officer now owns 101,337 shares […]